Assertio to Participate in Benchmark Healthcare Conference on May 21-22
Assertio Holdings announced that CFO Ajay Patel will participate in the Benchmark & Company Healthcare House Call Virtual Conference on May 21-22, 2024. Assertio, listed on Nasdaq under the ticker ASRT, specializes in providing differentiated pharmaceutical products. Investors interested in scheduling a meeting can do so through their Benchmark representative or by contacting Assertio's investor relations.
- Assertio's active participation in the Benchmark Healthcare Conference indicates proactive investor engagement.
- Opportunity for investors to have direct meetings with the CFO could enhance investor relations and confidence.
- Participation in a recognized healthcare conference could increase the visibility of Assertio's business and products.
- The press release does not mention new product launches, financial performance, or other substantive business developments.
- Potential for increased expenses related to conference participation without guaranteed returns.
- No specific updates on the company's operational or financial metrics, which might leave investors seeking more detailed information.
LAKE FOREST, Ill., May 17, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that Ajay Patel, Chief Financial Officer, will host investor meetings as part of the Benchmark & Company Healthcare House Call Virtual Conference, taking place May 21-22, 2024.
Investors participating in the Benchmark conference can request a meeting via their Benchmark representative, or contact Assertio investor relations via mkreps@darrowir.com.
About Assertio
Assertio is a commercial pharmaceutical company offering differentiated products to patients. We have built our commercial portfolio through acquisition or licensing of approved products. Our comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting, and trade and distribution. To learn more about Assertio, visit www.assertiotx.com.
Forward Looking Statements
Statements in this communication that are not historical facts are forward-looking statements that reflect Assertio’s current expectations, assumptions and estimates of future performance and economic conditions. These forward-looking statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to, among other things, future events or the future performance or operations of Assertio, including risks related to our ability to realize the benefits from our operating model, successfully integrate new assets, explore new business development initiatives, and successfully recruit a successor CEO on a timely basis. All statements other than historical facts may be forward-looking statements and can be identified by words such as “anticipate,” “believe,” “could,” “design,” “estimate,” “expect,” “forecast,” “goal,” “guidance,” “imply,” “intend,” “may,” “objective,” “opportunity,” “outlook,” “plan,” “position,” “potential,” “predict,” “project,” “prospective,” “pursue,” “seek,” “should,” “strategy,” “target,” “would,” “will,” “aim” or other similar expressions that convey the uncertainty of future events or outcomes and are used to identify forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond the control of Assertio, including the risks described in Assertio’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the U.S. Securities and Exchange Commission (“SEC”) and in other filings Assertio makes with the SEC from time to time. Investors and potential investors are urged not to place undue reliance on forward-looking statements in this communication, which speak only as of this date. While Assertio may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to update or revise any forward-looking-statements contained in this press release whether as a result of new information or future events, except as may be required by applicable law.
Investor Contact
Matt Kreps, Managing Director
Darrow Associates
M: 214-597-8200
mkreps@darrowir.com
FAQ
What is Assertio's stock symbol?
When is Assertio participating in the Benchmark Healthcare Conference?
Who from Assertio will participate in the Benchmark Conference?
How can investors schedule meetings with Assertio at the Benchmark Conference?
What type of company is Assertio?
